Biopharma and life science leaders are calling this patient-first approach "optionality": some participants prefer traveling to a trial site, while others can't due to cost or time constraints, and a...
Read More
20/20 Onsite is extremely passionate about providing a patient-centric healthcare experience to patients of all ages. Just last month, our Life Sciences team saw 44 patients,17 adult patients, and 27...
Read More
Clinical trials can see patient dropout rates as high as 30%, resulting in missed timelines or, in the worst cases, the discontinuation of trials altogether. We sat down with 20/20 Onsite's Chief...
Read More
People with language barriers often struggle to get the care they need, and they may even avoid seeking care altogether. At 20/20 Onsite, we want every patient who comes aboard a Mobile Vision Clinic...
Read More
Technological advancements, changing cultural expectations around data diversity, and “The Great Resignation” have all hit the life sciences industry at the same time as a global pandemic.
Read More
Often, the patient experience comes down to whom they interact with at the clinic. Patients need a care team who understands their community. Through a culturally sensitive patient experience,...
Read More
As the spring conference season comes to an end, we’re reflecting on what we learned and identifying practical ways we can support clinical researchers, healthcare providers, and patients. Because...
Read More
For decades, researchers and government agencies have had their eyes on diversity in clinical trials. On April 13, The U.S. Food and Drug Administration issued a draft guidance recommending that...
Read More